Acoustic Coordinated Reset (CR®) Neuromodulation for the Treatment of Chronic Tonal Tinnitus

Confirmation of efficacy and safety of acoustic CR neuromodulation for the treatment of tinnitus.

  1. Tinnitus Talk
    Confirmation of efficacy and safety of acoustic CR®-neuromodulation for the treatment of chronic tinnitus patients using the CE marked ANM T30 CR®-system in a real life outpatient setting.
    • Identification of early indicators for therapy success
    • Comparison of different patient groups regarding: tinnitus severity, tinnitus duration, level of hearing loss, stimulation patterns, unilateral monotonal vs. all other complex forms
    • Representative set of safety data in a broad patient spectrum
    • Measurement of tinnitus burden (TBF-12 Questionnaire)
    • Generation of longterm compliance data
    Estimated Enrollment: 200
    Study Start Date: November 2011
    Estimated Study Completion Date: July 2013
    Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)